Summary (continued)
Availability of Full Report
The full evidence report from which this summary was taken
was prepared for the Agency for Healthcare Research and
Quality (AHRQ) by the University of Ottawa Evidence-based
Practice Center under Contract No. 290-02-0021. Printed
copies may be obtained free of charge from the AHRQ
Publications Clearinghouse by calling 800-358-9295.
Requesters should ask for Evidence Report/Technology
Assessment No. 118, Effects of Omega-3 Fatty Acids on Child
and Maternal Health.
The Evidence Report is also online on the National Library of Medicine Bookshelf, or can be downloaded as a PDF File (3.3 MB). PDF Help.
Return to Contents
References
1. McCormick MC. The contribution of low birth weight to infant
mortality and childhood morbidity. N Engl J Med 1985; 312(2):82-90.
2. Lemons JA, Bauer CR, Oh W, et al. Very low birth weight
outcomes of the National Institute of Child health and human
development neonatal research network, January 1995 through
December 1996. NICHD Neonatal Research Network. Pediatrics
2001; 107(1):E1.
3. Vohr BR, Msall ME. Neuropsychological and functional outcomes
of very low birth weight infants. Semin Perinatol 1997; 21(3):202-20.
4. Saigal S. Follow-up of very low birthweight babies to adolescence.
Semin Neonatol 2000; 5(2):107-18.
5. Kramer MS, Demissie K, Yang H, et al. The contribution of mild
and moderate preterm birth to infant mortality. Fetal and Infant
Health Study Group of the Canadian Perinatal Surveillance System.
JAMA 2000; 284(7):843-49.
6. Olsen SF, Hansen HS, Sorensen TI, et al. Intake of marine fat, rich
in (n-3)-polyunsaturated fatty acids, may increase birthweight by
prolonging gestation. Lancet 1986; 2(8503):367-9.
7. Olsen SF. Consumption of marine n-3 fatty acids during pregnancy
as a possible determinant of birth weight. A review of the current
epidemiologic evidence [Review] [112 refs]. Epidemiol Rev 1993;
15(2):399-413.
8. Olsen SF, Hansen HS, Sorensen TI, et al. Intake of marine fat, rich
in (n-3)-polyunsaturated fatty acids, may increase birthweight by
prolonging gestation. Lancet 1986; 2(8503):367-9.
9. Andersen HJ, Andersen LF, Fuchs AR. Diet, pre-eclampsia, and
intrauterine growth retardation. Lancet 1989; 1(8647):1146.
10. Olsen SF, Olsen J, Frische G. Does fish consumption during
pregnancy increase fetal growth? A study of the size of the newborn,
placental weight and gestational age in relation to fish consumption
during pregnancy. Int J Epidemiol 1990; 19(4):971-7.
11. Olsen SF, Secher NJ, Tabor A, et al. Randomised clinical trials of
fish oil supplementation in high risk pregnancies. Fish Oil Trials In
Pregnancy (FOTIP) Team. BJOG 2000; 107(3):382-95.
12. Dyerberg J, Bang HO. Pre-eclampsia and prostaglandins. Lancet
1985; 1(8440).
13. England MJ, Atkinson PM, Sonnendecker EW. Pregnancy induced
hypertension: will treatment with dietary eicosapentaenoic acid be
effective? [Review] [50 refs]. Med Hypotheses 1987; 24(2):179-86.
14. Secher NJ, Olsen SF. Fish-oil and pre-eclampsia [comment]
[Review] [25 refs]. BJOG 1990; 97(12):1077-9.
15. Giusto NM, Pasquare SJ, Salvador GA, et al. Lipid metabolism in
vertebrate retinal rod outer segments. Prog Lipid Res 2000;
39(4):315-91.
16. Sastry PS. Lipids of nervous tissue: composition and metabolism.
Prog Lipid Res 1985; 24(2):69-176.
17. Innis S, Uauy R, Heird W, et al. Mechanisms of action of LC
PUFAs effects on infant growth and neurodevelopment: Perinatal
biochemistry and physiology of LC PUFAs discussion. J Pediatr
2003; 143(4 Suppl).
18. Carlson SE, Rhodes PG, Ferguson MG. Docosahexaenoic acid
status of preterm infants at birth and following feeding with human
milk or formula. Am J Clin Nutr 1986; 44(6):798-804.
19. Anderson JW, Johnstone BM, Remley DT. Breast-feeding and
cognitive development: A meta-analysis. Am J Clin Nutr 1999;
70(4).
20. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of
reports of meta-analyses of randomised controlled trials: the
QUOROM statement. Quality of Reporting of Meta-analyses.
Lancet 1999; 354(9193):1896-900.
21. Hofmann M, Bahlmann F, Pollow K, et al. Phospholipid and
triglycerid composition in patients with preeclampsia compared
with normal pregnancies—Deficiency of essential polyunsaturated
fatty acids. Geburtshilfe Frauenheilkd 1998; 58(9).
22. Olsen SF, Secher NJ, Tabor A, et al. Randomised clinical trials of
fish oil supplementation in high risk pregnancies. Fish Oil Trials In
Pregnancy (FOTIP) Team. BJOG 2000; 107(3):382-95.
23. Onwude JL, Lilford RJ, Hjartardottir H, et al. A randomised
double blind placebo controlled trial of fish oil in high risk
pregnancy. BJOG 1995; 102(2):95-100.
24. McClead REJr, Meng HC, Gregory SA, et al. Comparison of the
clinical and biochemical effect of increased alpha-linolenic acid in a
safflower oil intravenous fat emulsion. J Pediatr Gastroenterol Nutr
1985; 4(2):234-9.
25. Birch DG, Birch EE, Hoffman DR, et al. Retinal development in
very-low-birth-weight infants fed diets differing in omega-3 fatty
acids. Invest Ophthalmol Vis Sci 1992; 33(8):2365-76.
26. Koletzko B, Edenhofer S, Lipowsky G, et al. Effects of a low
birthweight infant formula containing human milk levels of
docosahexaenoic and arachidonic acids. J Pediatr Gastroenterol Nutr
1995; 21(2):200-8.
27. Vanderhoof J, Gross S, Hegyi T, et al. Evaluation of a long-chain
polyunsaturated fatty acid supplemented formula on growth,
tolerance, and plasma lipids in preterm infants up to 48 weeks
postconceptional age. J Pediatr Gastroenterol Nutr 1999; 29(3):318-26.
28. O'Connor DL, Hall R, Adamkin D, et al. Growth and
development in preterm infants fed long-chain polyunsaturated fatty
acids: a prospective, randomized controlled trial. Pediatrics 2001;
108(2):359-71.
29. Innis SM, Adamkin DH, Hall RT, et al. Docosahexaenoic acid and
arachidonic acid enhance growth with no adverse effects in preterm
infants fed formula. J Pediatr 2002; 140(5):547-54.
30. Clandinin MTV. Growth and development of very-low-birth-weight
infants (VLBW) is enhanced by formulas supplemented with
docosahexaenoic acid (DHA) and arachidonic acid (ARA). J Pediatr Gastroenterol Nutr 2002; 34(4):479.
31. Fewtrell MS, Morley R, Abbott RA, et al. Double-blind,
randomized trial of long-chain polyunsaturated fatty acid
supplementation in formula fed to preterm infants. Pediatrics 2002;
110(1):73-82.
32. Koletzko B, Sauerwald U, Keicher U, et al. Fatty acid profiles,
antioxidant status, and growth of preterm infants fed diets without
or with long-chain polyunsaturated fatty acids: A randomized
clinical trial. Eur J Nutr 2003; 42(5).
33. Gobel Y, Koletzko B, Bohles HJ, et al. Parenteral fat emulsions
based on olive and soybean oils: a randomized clinical trial in
preterm infants. J Pediatr Gastroenterol Nutr 2003; 37(2):161-7.
34. Fewtrell MS, Abbott RA, Kennedy K, et al. Randomized, doubleblind
trial of long-chain polyunsaturated fatty acid supplementation
with fish oil and borage oil in preterm infants. J Pediatr 2004;
144(4):471-9.
35. Decsi T, Koletzko B. Growth, fatty acid composition of plasma lipid
classes, and plasma retinol and alpha-tocopherol concentrations in
full-term infants fed formula enriched with omega-6 and omega-3
long-chain polyunsaturated fatty acids. Acta Paediatr 1995;
84(7):725-32.
36. Auestad N, Montalto MB, Hall RT, et al. Visual acuity, erythrocyte
fatty acid composition, and growth in term infants fed formulas
with long chain polyunsaturated fatty acids for one year. Ross
Pediatric Lipid Study. Pediatr Res 1997; 41(1):1-10.
37. Birch EE, Hoffman DR, Uauy R, et al. Visual acuity and the
essentiality of docosahexaenoic acid and arachidonic acid in the diet
of term infants. Pediatr Res 1998; 44(2):201-9.
38. Lucas A, Stafford M, Morley R, et al. Efficacy and safety of longchain
polyunsaturated fatty acid supplementation of infant-formula
milk: a randomised trial [comment]. Lancet 1999; 354(9194):1948-54.
39. Makrides M, Neumann MA, Simmer K, et al. Dietary long-chain
polyunsaturated fatty acids do not influence growth of term infants:
A randomized clinical trial. Pediatrics 1999; 104(3 Pt 1):468-75.
40. Morris G, Moorcraft J, Mountjoy A, et al. A novel infant formula
milk with added long-chain polyunsaturated fatty acids from singlecell
sources: a study of growth, satisfaction and health. Eur J Clin Nutr 2000; 54(12):883-6.
41. Makrides M, Neumann MA, Jeffrey B, et al. A randomized trial of
different ratios of linoleic to alpha-linolenic acid in the diet of term
infants: effects on visual function and growth [comment]. Am J Clin Nutr 2000; 71(1):120-9.
42. Auestad N, Halter R, Hall RT, et al. Growth and development in
term infants fed long-chain polyunsaturated fatty acids: a double-masked,
randomized, parallel, prospective, multivariate study.
Pediatrics 2001; 108(2):372-81.
43. Jensen CL, Prager TC, Fraley JK, et al. Effect of dietary
linoleic/alpha-linolenic acid ratio on growth and visual function of
term infants [comment]. J Pediatr 1997; 131(2):200-9.
44. Olsen SF, Sorensen JD, Secher NJ, et al. Randomised controlled
trial of effect of fish-oil supplementation on pregnancy
duration. [comment]. Lancet 1992; 339(8800):1003-7.
45. Helland IB, Saugstad OD, Smith L, et al. Similar effects on infants
of n-3 and n-6 fatty acids supplementation to pregnant and
lactating women. Pediatrics 2001; 108(5):E82.
46. Dunstan JA, Mori TA, Barden A, et al. Effects of n-3
polyunsaturated fatty acid supplementation in pregnancy on
maternal and fetal erythrocyte fatty composition. Eur J Clin Nutr
2004; 58(3):429-37.
47. Smuts CM, Borod E, Peeples JM, et al. High-DHA eggs: feasibility
as a means to enhance circulating DHA in mother and infant.
Lipids 2003; 38(4):407-14.
48. de Groot RH, Hornstra G, van Houwelingen AC, et al. Effect of
alpha-linolenic acid supplementation during pregnancy on maternal
and neonatal polyunsaturated fatty acid status and pregnancy
outcome. Am J Clin Nutr 2004; 79(2):251-60.
49. Onwude JL, Lilford RJ, Hjartardottir H, et al. A randomised
double blind placebo controlled trial of fish oil in high risk
pregnancy. BJOG 1995; 102(2):95-100.
50. Smuts CM, Huang M, Mundy D, et al. A randomized trial of
docosahexaenoic acid supplementation during the third trimester of
pregnancy. Obstet Gynecol 2003; 101(3):469-79.
51. Malcolm CA, Hamilton R, McCulloch DL, et al. Scotopic
electroretinogram in term infants born of mothers supplemented
with docosahexaenoic acid during pregnancy. Invest Ophthalmol Vis Sci 2003; 44(8):3685-91.
52. Olsen SF, Sorensen JD, Secher NJ, et al. Randomised controlled
trial of effect of fish-oil supplementation on pregnancy
duration [comment]. Lancet 1992; 339(8800):1003-7.
53. Dunstan JA, Mori TA, Barden A, et al. Effects of n-3
polyunsaturated fatty acid supplementation in pregnancy on
maternal and fetal erythrocyte fatty composition. Eur J Clin Nutr
2004; 58(3):429-37.
54. Helland IB, Saugstad OD, Smith L, et al. Similar effects on infants
of n-3 and n-6 fatty acids supplementation to pregnant and
lactating women. Pediatrics 2001; 108(5):E82.
55. Smuts CM, Huang M, Mundy D, et al. A randomized trial of
docosahexaenoic acid supplementation during the third trimester of
pregnancy. Obstet Gynecol 2003; 101(3):469-79.
56. Malcolm CA, Hamilton R, McCulloch DL, et al. Scotopic
electroretinogram in term infants born of mothers supplemented
with docosahexaenoic acid during pregnancy. Invest Ophthalmol Vis Sci 2003; 44(8):3685-91.
57. Smuts CM, Borod E, Peeples JM, et al. High-DHA eggs: feasibility
as a means to enhance circulating DHA in mother and infant.
Lipids 2003; 38(4):407-14.
58. de Groot RH, Hornstra G, van Houwelingen AC, et al. Effect of
alpha-linolenic acid supplementation during pregnancy on maternal
and neonatal polyunsaturated fatty acid status and pregnancy
outcome. Am J Clin Nutr 2004; 79(2):251-60.
59. Bulstra-Ramakers MT, Huisjes HJ, Visser GH. The effects of 3g
eicosapentaenoic acid daily on recurrence of intrauterine growth
retardation and pregnancy induced hypertension. Br J Obstet
Gynaecol 1995; 102(2):123-26.
60. Elias SL, Innis SM. Infant plasma trans, n-6, and n-3 fatty acids and
conjugated linoleic acids are related to maternal plasma fatty acids,
length of gestation, and birth weight and length [comment]. Am J Clin Nutr 2001; 73(4):807-14.
61. Rump P, Mensink RP, Kester AD, et al. Essential fatty acid
composition of plasma phospholipids and birth weight: a study in
term neonates [comment]. Am J Clin Nutr 2001; 73(4):797-806.
62. Reece MS, McGregor JA, Allen KG, et al. Maternal and perinatal
long-chain fatty acids: possible roles in preterm birth [comment].
Am J Obstet Gynecol 1997; 176(4):907-14.
63. Laivuori H, Hovatta O, Viinikka L, et al. Dietary supplementation
with primrose oil or fish oil does not change urinary excretion of
prostacyclin and thromboxane metabolites in pre-eclamptic women.
Prostaglandins Leukot Essent Fatty Acids 1993; 49(3):691-94.
64. D'Almeida A, Carter JP, Anatol A, et al. Effects of a combination of
evening primrose oil (gamma linolenic acid) and fish oil
(eicosapentaenoic + docahexaenoic acid) versus magnesium, and
versus placebo in preventing pre-eclampsia. Women Health 1992;
19(2-3):117-31.
65. Al MD, van Houwelingen AC, Badart-Smook A, et al. The essential
fatty acid status of mother and child in pregnancy-induced
hypertension: a prospective longitudinal study. Am J Obstet Gynecol 1995; 172(5):1605-14.
66. Craig-Schmidt MC, Carlson SE, Crocker L, et al. Plasma total
phospholipid arachidonic acid and eicosapentaenoic acid in normal
and hypertensive pregnancy. World Rev Nutr Diet 1994; 76:126-9.
67. Shouk TA, Omar MN, Fayed ST. Essential fatty acids profile and
lipid peroxides in severe pre-eclampsia. Ann Clin Biochem 1999;
36(Pt 1):62-5.
68. Wang YP, Kay HH, Killam AP. Decreased levels of polyunsaturated
fatty acids in preeclampsia.[comment]. Am J Obstet Gynecol 1991;
164(3):812-8.
69. Vilbergsson G, Samsioe G, Wennergren M, et al. Essential fatty
acids in pregnancies complicated by intrauterine growth retardation.
Int J Gynaecol Obstet 1991; 36(4):277-86.
70. Matorras R, Perteagudo L, Nieto A, et al. Intrauterine growth
retardation and plasma fatty acids in the mother and the fetus. Eur J Obstet Gynecol Reprod Biol 1994; 57(3):189-93.
71. Cetin I, Giovannini N, Alvino G, et al. Intrauterine growth
restriction is associated with changes in polyunsaturated fatty acid
fetal-maternal relationships. Pediatr Res 2002; 52(5):750-5.
72. Jensen CL, Prager TC, Zou Y, et al. Effects of maternal
docosahexaenoic acid supplementation on visual function and
growth of breast-fed term infants. Lipids 1999; 34(Suppl):S225.
73. Rocquelin G, Tapsoba S, Kiffer J, et al. Human milk fatty acids and
growth of infants in Brazzaville (The Congo) and Ouagadougou
(Burkina Faso). Public Health Nutr 2003; 6(3):241-8.
74. Xiang M, Alfven G, Blennow M, et al. Long-chain polyunsaturated
fatty acids in human milk and brain growth during early infancy.
Acta Paediatr 2000; 89(2):142-47.
75. Carlson SE, Rhodes PG, Rao VS, et al. Effect of fish oil
supplementation on the n-3 fatty acid content of red blood cell
membranes in preterm infants. Pediatr Res 1987; 21(5):507-10.
76. Carlson SE, Cooke RJ, Werkman SH, et al. First year growth of
preterm infants fed standard compared to marine oil n-3
supplemented formula. Lipids 1992; 27(11):901-7.
77. Faldella G, Govoni M, Alessandroni R, et al. Visual evoked
potentials and dietary long chain polyunsaturated fatty acids in
preterm infants. Arch Dis Child Fetal Neonatal Ed 1996;
75(2):F108-F112.
78. Lapillonne A, Picaud JC, Chirouze V, et al. Supplementation of
preterm formulas (PTF) with a low EPA fish oil: Effect on
polyunsaturated fatty acids(PUfatty acidsS) status and growth. J Pediatr Gastroenterol Nutr 1997; 24(4).
79. Woltil HA, van Beusekom CM, Okken-Beukens M, et al.
Development of low-birthweight infants at 19 months of age
correlates with early intake and status of long-chain polyunsaturated
fatty acids. Prostaglandins Leukot Essent Fatty Acids 1999;
61(4):235-41.
80. Martinez FE, Santos MMd, Sieber VM, et al. Growth and nitrogen
balance in preterm infants fed formula with long chain
polyunsaturated fatty acids. Nutr Res 1999; 19(10):1497-505.
81. Ghebremeskel K, Burns L, Costeloe K, et al. Plasma vitamin A and
E in preterm babies fed on breast milk or formula milk with or
without long-chain polyunsaturated fatty acids. Int J Vitam Nutr
Res 1999; 69(2):83-91.
82. Bougle D, Denise P, Vimard F, et al. Early neurological and
neuropsychological development of the preterm infant and
polyunsaturated fatty acids supply. Clin Neurophysiol 1999;
110(8):1363-70.
83. Boue C, Combe N, Billeaud C, et al. Nutritional implications of
trans fatty acids during perinatal period, in French pregnant women.
Lipids, fats and oils: opportunities and responsibilities in the New
Century 2001; 8(1):68-72.
84. Groh-Wargo S, Moore JJ, Catalano P, et al. Docosahexaenoic acid
(DHA) and arachidonic acid (AA) supplementation does not change
body composition in preterm (PT) infants. Pediatr Res 2002;
51(4):380A.
85. Carlson SE, Werkman SH, Tolley EA. Effect of long-chain n-3 fatty
acid supplementation on visual acuity and growth of preterm infants
with and without bronchopulmonary dysplasia. Am J Clin Nutr
1996; 63(5):687-97.
86. Ponder DL, Innis SM, Benson JD, et al. Docosahexaenoic acid
status of term infants fed breast milk or infant formula containing
soy oil or corn oil. Pediatr Res 1992; 32(6):683-8.
87. Makrides M, Neumann M, Simmer K, et al. Are long-chain
polyunsaturated fatty acids essential nutrients in infancy? [comment].
Lancet 1995; 345(8963):1463-8.
88. Innis SM, Akrabawi SS, Diersen-Schade DA, et al. Visual acuity
and blood lipids in term infants fed human milk or
formulae [erratum appears in Lipids 1997 Apr;32(4):457]. Lipids
1997; 32(1):63-72.
89. Jorgensen MH, Holmer G, Lund P, et al. Effect of formula
supplemented with docosahexaenoic acid and gamma-linolenic acid
on fatty acid status and visual acuity in term infants. J Pediatr Gastroenterol Nutr 1998; 26(4):412-21.
90. Lapillonne A. Erythrocyte fatty acid composition in term infants fed
human milk or a formula enriched with a low eicosapentanoic acid
fish oil for 4 months. Eur J Pediatr 2000; 159(1-2):49-53.
91. Birch EE, Hoffman DR, Castaneda YS, et al. A randomized
controlled trial of long-chain polyunsaturated fatty acid
supplementation of formula in term infants after weaning at 6 wk of
age. Am J Clin Nutr 2002; 75(3):570-80.
92. Willatts P, Forsyth JS, DiModugno MK, et al. Effect of long-chain
polyunsaturated fatty acids in infant formula on problem solving at
10 months of age. Lancet, British edition 1998; 352(9129):688-91.
93. Hoffman DR, Birch EE, Castaneda YS, et al. Visual function in
breast-fed term infants weaned to formula with or without longchain
polyunsaturates at 4 to 6 months: a randomized clinical trial. J Pediatr 2003; 142(6):669-77.
94. Jensen CL, Prager TC, Fraley JK, et al. Effect of dietary
linoleic/alpha-linolenic acid ratio on growth and visual function of
term infants [comment]. J Pediatr 1997; 131(2):200-9.
95. Makrides M, Neumann MA, Jeffrey B, et al. A randomized trial of
different ratios of linoleic to alpha-linolenic acid in the diet of term
infants: effects on visual function and growth [comment]. Am J Clin Nutr 2000; 71(1):120-9.
96. Lapillonne A. Erythrocyte fatty acid composition in term infants fed
human milk or a formula enriched with a low eicosapentanoic acid
fish oil for 4 months. Eur J Pediatr 2000; 159(1-2):49-53.
97. Morris G, Moorcraft J, Mountjoy A, et al. A novel infant formula
milk with added long-chain polyunsaturated fatty acids from singlecell
sources: a study of growth, satisfaction and health. Eur J Clin Nutr 2000; 54(12):883-6.
98. Auestad N, Halter R, Hall RT, et al. Growth and development in
term infants fed long-chain polyunsaturated fatty acids: a double-masked,
randomized, parallel, prospective, multivariate study.
Pediatrics 2001; 108(2):372-81.
99. Guesnet P. Blood lipid concentrations of docosahexaenoic and
arachidonic acids at birth determine their relative postnatal changes
in term infants fed breast milk or formula [comment]. Am J Clin
Nutr 1999; 70(2):292-8.
100. Innis SM, Gilley J, Werker J. Are human milk long-chain
polyunsaturated fatty acids related to visual and neural development
in breast-fed term infants? J Pediatr 2001; 139(4):532-8.
101. Gibson RA, Neumann MA, Makrides M. Effect of increasing breast
milk docosahexaenoic acid on plasma and erythrocyte phospholipid
fatty acids and neural indices of exclusively breast fed infants. Eur J
Clin Nutr 1997; 51(9):578-84.
102. Agostoni C, Marangoni F, Giovannini M, et al. Prolonged breastfeeding
(six months or more) and milk fat content at six months are
associated with higher developmental scores at one year of age
within a breast-fed population. Adv Exp Med Biol 2001; 501:137-41.
103. Wezel-Meijler G, van der Knaap MS, Huisman J, et al. Dietary
supplementation of long-chain polyunsaturated fatty acids in
preterm infants: effects on cerebral maturation. Acta Paediatr 2002;
91(9):942-50.
104. Agostoni C, Trojan S, Bellu R, et al. Neurodevelopmental quotient
of healthy term infants at 4 months and feeding practice: the role of
long-chain polyunsaturated fatty acids. Pediatr Res 1995; 38(2):262-6.
105. Cheruku SR, Montgomery-Downs HE, Farkas SL, et al. Higher
maternal plasma docosahexaenoic acid during pregnancy is
associated with more mature neonatal sleep-state patterning. Am J Clin Nutr 2002; 76(3):608-13.
106. Krasevec JM, Jones PJ, Cabrera-Hernandez A, et al. Maternal and
infant essential fatty acid status in Havana, Cuba. Am J Clin Nutr
2002; 76(4):834-44.
107. Jorgensen MH, Hernell O, Hughes EL, et al. Is there a relation
between docosahexaenoic acid concentration in mothers' milk and
visual development in term infants? J Pediatr Gastroenterol Nutr
2001; 32(3):293-6.
108. Williams C, Birch EE, Emmett PM, et al. Stereoacuity at age 3.5 y
in children born full-term is associated with prenatal and postnatal
dietary factors: a report from a population-based cohort study. Am J Clin Nutr 2001; 73(2):316-22.
109. Baker PN. Possible dietary measures in the prevention of preeclampsia
and eclampsia [Review] [73 refs]. Baillieres Clin Obstet
Gynaecol 1995; 9(3):497-507.
110. Carlson SE, Ford AJ, Werkman SH, et al. Visual acuity and fatty
acid status of term infants fed human milk and formulas with and
without docosahexaenoate and arachidonate from egg yolk lecithin.
Pediatr Res 1996; 39(5):882-8.
111. Birch E, Birch D, Hoffman D, et al. Breast-feeding and optimal
visual development. J Pediatr Ophthalmol Strabismus 1993;
30(1):33-8.
112. Leaf A, Gosbell A, McKenzie L, et al. Long chain polyunsaturated
fatty acids and visual function in preterm infants. Early Hum Dev
1996; 45(1-2):35-53.
113. Makrides M, Simmer K, Goggin M, et al. Erythrocyte
docosahexaenoic acid correlates with the visual response of healthy,
term infants. Pediatr Res 1993; 33(4 Pt 1):425-7.
114. Innis SM, Nelson CM, Rioux MF, et al. Development of visual
acuity in relation to plasma and erythrocyte omega-6 and omega-3
fatty acids in healthy term gestation infants. Am J Clin Nutr 1994;
60(3):347-52.
115. Jorgensen MH, Hernell O, Lund P, et al. Visual acuity and
erythrocyte docosahexaenoic acid status in breast-fed and formula-fed
term infants during the first four months of life. Lipids 1996;
31(1):99-105.
116. Su HM, Huang MC, Saad NM, et al. Fetal baboons convert 18:3n-3 to 22:6n-3 in vivo. A stable isotope tracer study. J Lipid Res 2001;
42(4):581-86.
117. Lucas A, Stafford M, Morley R, et al. Efficacy and safety of longchain
polyunsaturated fatty acid supplementation of infant-formula
milk: a randomised trial [comment]. Lancet 1999; 354(9194):1948-54.
118. Ghys A, Bakker E, Hornstra G, et al. Red blood cell and plasma
phospholipid arachidonic and docosahexaenoic acid levels at birth
and cognitive development at 4 years of age. Early Hum Dev 2002;
69(1-2):83-90.
Return to Contents
AHRQ Publication Number 05-E025-1
Current as of August 2005
Internet Citation:
Authors: Lewin GA, Schachter HM, Yuen D, et al. Effects of Omega-3 Fatty Acids on Child and Maternal Health. Summary, Evidence Report/Technology Assessment:
Number 118. AHRQ Publication Number 05-E025-1, August 2005. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/epcsums/o3mchsum.htm
540 Gaither Road Rockville, MD 20850